Search

Your search keyword '"Ganz P.A."' showing total 154 results

Search Constraints

Start Over You searched for: Author "Ganz P.A." Remove constraint Author: "Ganz P.A."
154 results on '"Ganz P.A."'

Search Results

1. A bio-behavioral model of systemic inflammation at breast cancer diagnosis and fatigue of clinical importance 2 years later

2. ESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in Europe

4. Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis

5. 1st International consensus guidelines for advanced breast cancer (ABC 1)

6. Polygenic risk modeling for prediction of epithelial ovarian cancer risk

7. Evaluating Treatment Tolerability Using the Toxicity Index With Patient-Reported Outcomes Data

11. Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study

12. The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant

13. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants.

16. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

17. Current state of quality of life and patient-reported outcomes research

18. Shared heritability and functional enrichment across six solid cancers (vol 10, 431, 2019)

19. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

20. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.

21. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status.

22. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status

24. Cosmetic Outcome from Post Lumpectomy Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) on the NRG Oncology/NSABP B39-RTOG 0413 Phase III Clinical Trial

25. Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers

26. Shared heritability and functional enrichment across six solid cancers.

27. Publisher Correction: Shared heritability and functional enrichment across six solid cancers (Nature Communications, (2019), 10, 1, (431), 10.1038/s41467-018-08054-4).

28. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer.

29. Erratum: Publisher Correction: Shared heritability and functional enrichment across six solid cancers (Nature communications (2019) 10 1 (431))

31. Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

33. BRCA2 polymorphic stop codon K3326X and the risk of breast, prostate, and ovarian cancers

34. A Nonsynonymous Polymorphism in IRS1 Modifies Risk of Developing Breast and Ovarian Cancers in BRCA1 and Ovarian Cancer in BRCA2 Mutation Carriers

35. Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

39. Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3

40. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

42. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

43. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

44. BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

45. Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3

46. Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women

47. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

48. Assessing the impact of cancer among Dutch non-Hodgkin lymphoma survivors compared with their American counterparts: A cross-national study

49. Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

50. Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer

Catalog

Books, media, physical & digital resources